{"web_url": "http://www.nytimes.com/2015/09/22/business/big-price-increase-for-tb-drug-is-rescinded.html", "multimedia": [], "subsection_name": null, "print_page": "3", "blog": [], "section_name": "Business Day", "abstract": "Rodelis Therapeutics,which bought tuberculosis drug cycloserine from nonprofit Purdue Research Foundation and promptly raised price from $500 to $10,800 for 30 capsules, agrees to give drug back to foundation, which will raise price to only $1,050; Turing Pharmaceuticals, which bought and dramatically raised price of drug Daraprim, is unapologetic about move;  relatively new business strategy of buying old drugs and raising prices has been widely condemned.", "type_of_material": "News", "lead_paragraph": "Rodelis, which acquired cycloserine and promptly raised its price more than twentyfold, returned it to the foundation that had previously owned the drug.", "keywords": [{"value": "Rodelis Therapeutics", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Purdue Research Foundation", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Turing Pharmaceuticals AG", "name": "organizations", "rank": "4", "is_major": "Y"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Tuberculosis", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Toxoplasmosis", "name": "subject", "rank": "8", "is_major": "N"}, {"value": "Sanders, Bernard", "name": "persons", "rank": "9", "is_major": "N"}, {"value": "Clinton, Hillary Rodham", "name": "persons", "rank": "10", "is_major": "N"}], "_id": "5600597738f0d813baf6c072", "pub_date": "2015-09-22T00:00:00Z", "byline": {"original": "By ANDREW POLLACK", "person": [{"role": "reported", "firstname": "Andrew", "organization": "", "rank": 1, "lastname": "POLLACK"}]}, "news_desk": "Business", "slideshow_credits": null, "word_count": "1014", "source": "The New York Times", "headline": {"main": "Big Price Increase for Tuberculosis Drug Is Rescinded", "print_headline": "Price Increase Rescinded for a Tuberculosis Drug"}, "snippet": "Rodelis, which acquired cycloserine and promptly raised its price more than twentyfold, returned it to the foundation that had previously owned the drug....", "document_type": "article"}